Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease
- 1 February 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (3) , 422-426
- https://doi.org/10.1016/s0002-9149(83)80073-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981
- Flecainide acetate, a new antiarrhythmic agent: Dose-ranging and efficacy studyThe American Journal of Cardiology, 1981
- Hemodynamic effects of newer antiarrhythmic drugsAmerican Heart Journal, 1980
- Evaluation of methods for quantitating left ventricular segmental wall motion in man using myocardial markers as a standard.Circulation, 1980
- Antiarrhythmic effects of flecainideClinical Pharmacology & Therapeutics, 1980
- Antiarrhythmic and Hemodynamic Actions of Flecainide Acetate (R-818) in the Ischemic Porcine HeartJournal of Cardiovascular Pharmacology, 1979
- Contrast Media in Coronary Arteriography: A ReviewInvestigative Radiology, 1978
- The hemodynamic effects of intravenous tocainide in patients with heart disease.Circulation, 1978
- Effects of contrast medium on left ventricular pressure and volume with emphasis on coronary artery diseaseAmerican Heart Journal, 1977
- Changes in left ventricular function produced by the injection of contrast mediaAmerican Heart Journal, 1972